USPTO serial 87117671
CANDOL
Reviewed by CopyMark Law Group
Reg. 5353118Status 710
- Filing date
- Status date
- Registration date
- Dec 12, 2017
- Examiner
- SHARPER JR, SAM
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with CANDOL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical preparations in the nature of pharmaceuticals for the treatment of pain, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, glaucoma, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and hepatic, renal, intestinal, autoimmune, metabolic, neurological, dermatological and cardiovascular disorders; sanitary preparations for medical purposes; vaccines; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations for injection for the treatment of pain, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; drug delivery agents in the form of liquid medications, tablets, powders, capsules, inhalers, nasal sprays, orally disintegrating tablets, mouthwashes, that facilitate the delivery of pharmaceutical preparations; medicated transdermal drug delivery patches for use in the treatment of pain, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; none of the aforementioned containing natural borage oil, being nutritional supplements, medicinal ointments, capsules for medicines, medicinal oils, dermatological preparations or for use in dermatology or in dietetics | SECTION 8 - CANCELLED | — |
| 010 | Inhalers for medical purposes; filters for inhalers for medical purposes; inhalers for medical use; inhalers for therapeutic use; drug delivery systems; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; microneedle arrays for delivering medications; hypodermic syringes for injections for medical purposes; non-medicated transdermal drug delivery patches; medical apparatus and instruments for the treatment of pain, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; medical apparatus and instruments for use in surgery | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 28, 2024 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Sep 14, 2023 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Sep 14, 2023 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Dec 12, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 12, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 26, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 26, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 6, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 21, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 21, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 16, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jul 24, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 27, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 27, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 27, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 26, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 25, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 25, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 8, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 1, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 30, 2016 | NWAP | NEW APPLICATION ENTERED | — |